Lisata Therapeutics Inc
F:8NE
Lisata Therapeutics Inc
F:8NE
Price:
3.06
EUR
3.38%
Market Closed
Market Cap:
€25.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lisata Therapeutics Inc
F:8NE
|
US |
|
T
|
Tecnicas Reunidas SA
MAD:TRE
|
ES |
|
MRC Global Inc
F:37M
|
US |
|
G
|
GFPT PCL
SET:GFPT
|
TH |
Wall St Price Targets
8NE Price Targets Summary
Lisata Therapeutics Inc
Lisata Therapeutics Inc
Wall Street analysts forecast 8NE stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 8NE is 5.55 EUR with a low forecast of 2.31 EUR and a high forecast of 9.01 EUR.
Lowest Forecast
Price Target
2.31
EUR
24% Downside
Average Forecast
Price Target
5.55
EUR
81% Upside
Highest Forecast
Price Target
9.01
EUR
195% Upside
Lisata Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8NE's stock price target?
Price Target
5.55
EUR
5.55
EUR
According to Wall Street analysts, the average 1-year price target for 8NE is 5.55 EUR with a low forecast of 2.31 EUR and a high forecast of 9.01 EUR.
What is the Revenue forecast for Lisata Therapeutics Inc?
Projected CAGR
237%
237%
Over the last 14 years, the compound annual growth rate for Revenue has been -25%. The projected CAGR for the next 6 years is 237%.
